UKKi020-B
NP0100-8
iPSC line
At European Collection of Authenticated Cell Cultures (ECACC)
A CLIP contains information about a cell line including any
specific third party obligations relating to, for example,
licensing obligations or the donor consent which affect the
use of the cell line.
A batch specific Certificate of Analysis will be available to
download once you receive your EBiSC iPSC line.
General#
Cell Line |
|
hPSCreg Name | UKKi020-B |
Alternative name(s) |
NP0100-8
|
Cell line type | Human induced pluripotent stem cell (hiPSC) |
Provider |
|
Depositor | Klinikum der Universität zu Köln (UKK) |
Owner | Institute for Neurophysiology, Medical Faculty |
Distributors |
EBiSC
European Collection of Authenticated Cell Cultures (ECACC)
|
Derivation country | Germany |
External Databases |
|
hPSCreg | UKKi020-B |
BioSamples | SAMEA103988343 |
Cellosaurus | CVCL_LD19 |
ECACC | 66540562 |
CLO | CLO_0100875 |
Wikidata | Q54990473 |
General Information |
|
* Is the cell line readily obtainable for third parties? |
Yes Research use: allowed
Clinical use: allowed
Commercial use: allowed
|
Donor Information#
General Donor Information |
|
Sex | male |
Age of donor (at collection) | 30-34 |
Ethnicity | african |
Phenotype and Disease related information (Donor) |
|
Diseases | No disease was diagnosed.
|
Disease associated phenotypes | no phenotypes |
Karyotyping (Donor) |
|
Has the donor karyotype been analysed? |
Yes
Karyotyping method:
Molecular karyotyping by SNP array
|
Other Genotyping (Donor) |
|
Is there genome-wide genotyping or functional data available? |
No
|
Donor Relations |
|
Other cell lines of this donor | |
External Databases (Donor) |
|
BioSamples | SAMEA17628418 |
hIPSC Derivation#
General |
|
Source cell type |
fibroblast of dermis |
Age of donor (at collection) | 30-34 |
Collected in | 2016 |
Passage number reprogrammed | 3 |
Reprogramming method |
|
Vector type | Non-integrating |
Vector | Episomal |
Is reprogramming vector detectable? |
No |
Methods used |
PCR
|
Notes on reprogramming vector detection | episomal vector cassette absence |
Files and images showing reprogramming vector expressed or silenced | |
Vector free reprogramming |
|
Type of used vector free reprogramming factor(s) |
None
|
Other |
|
Selection criteria for clones | morphology |
Derived under xeno-free conditions |
Yes |
Derived under GMP? |
No |
Available as clinical grade? |
No |
Culture Conditions#
The following are the depositor culture conditions, they do not refer to any specific batch.
Surface coating | Vitronectin | |||||||||
Feeder cells |
No |
|||||||||
Passage method |
Enzyme-free cell dissociation
EDTA
|
|||||||||
O2 Concentration | 20 % | |||||||||
CO2 Concentration | 5 % | |||||||||
Medium |
Essential 8™
Supplements
|
|||||||||
Has Rock inhibitor (Y27632) been used at passage previously with this cell line? | No |
|||||||||
Has Rock inhibitor (Y27632) been used at cryo previously with this cell line? | No |
|||||||||
Has Rock inhibitor (Y27632) been used at thaw previously with this cell line? | No |
Characterisation#
Analysis of Undifferentiated Cells
Differentiation Potency
In vitro directed differentiation
Marker | Expressed |
BRACHYURY |
Yes |
Microbiology / Virus Screening |
|
HIV 1 | Negative |
HIV 2 | Negative |
Hepatitis B | Negative |
Hepatitis C | Negative |
Mycoplasma | Negative |
Sterility |
|
Inoculation for microbiological growth | No Contaminants Detected |
Mycoplasma | Not Detected |
Viability | Viable post-cryopreservation |
Genotyping#
Karyotyping (Cell Line) |
|
Has the cell line karyotype been analysed? |
Yes
No larger chromosomal aberrations observed
Passage number: 26
Karyotyping method:
Molecular karyotyping by SNP array
|
Other Genotyping (Cell Line) |